rs41298498

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001008537.3(NEXMIF):​c.2598C>A​(p.Ser866Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0183 in 1,209,789 control chromosomes in the GnomAD database, including 167 homozygotes. There are 7,772 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 17 hom., 565 hem., cov: 23)
Exomes 𝑓: 0.019 ( 150 hom. 7207 hem. )

Consequence

NEXMIF
NM_001008537.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.305

Publications

0 publications found
Variant links:
Genes affected
NEXMIF (HGNC:29433): (neurite extension and migration factor) An inversion on the X chromosome which disrupts this gene and a G-protein coupled purinergic receptor gene located in the pseudoautosomal region of the X chromosome has been linked to X linked cognitive disability.[provided by RefSeq, Mar 2009]
NEXMIF Gene-Disease associations (from GenCC):
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability, Cantagrel type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-74741959-G-T is Benign according to our data. Variant chrX-74741959-G-T is described in ClinVar as Benign. ClinVar VariationId is 129383.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.305 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0157 (1752/111916) while in subpopulation SAS AF = 0.0464 (124/2672). AF 95% confidence interval is 0.0398. There are 17 homozygotes in GnomAd4. There are 565 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 Unknown,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEXMIFNM_001008537.3 linkc.2598C>A p.Ser866Ser synonymous_variant Exon 3 of 4 ENST00000055682.12 NP_001008537.1 Q5QGS0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEXMIFENST00000055682.12 linkc.2598C>A p.Ser866Ser synonymous_variant Exon 3 of 4 1 NM_001008537.3 ENSP00000055682.5 Q5QGS0
NEXMIFENST00000616200.2 linkc.2598C>A p.Ser866Ser synonymous_variant Exon 3 of 5 1 ENSP00000480284.1 Q5QGS0
NEXMIFENST00000642681.2 linkc.2598C>A p.Ser866Ser synonymous_variant Exon 3 of 3 ENSP00000495800.1 A0A2R8YEQ5

Frequencies

GnomAD3 genomes
AF:
0.0157
AC:
1752
AN:
111859
Hom.:
17
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00260
Gnomad AMI
AF:
0.00732
Gnomad AMR
AF:
0.0164
Gnomad ASJ
AF:
0.00189
Gnomad EAS
AF:
0.000562
Gnomad SAS
AF:
0.0459
Gnomad FIN
AF:
0.0410
Gnomad MID
AF:
0.00840
Gnomad NFE
AF:
0.0206
Gnomad OTH
AF:
0.0126
GnomAD2 exomes
AF:
0.0206
AC:
3782
AN:
183174
AF XY:
0.0226
show subpopulations
Gnomad AFR exome
AF:
0.00205
Gnomad AMR exome
AF:
0.0150
Gnomad ASJ exome
AF:
0.000936
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0449
Gnomad NFE exome
AF:
0.0198
Gnomad OTH exome
AF:
0.0148
GnomAD4 exome
AF:
0.0186
AC:
20424
AN:
1097873
Hom.:
150
Cov.:
32
AF XY:
0.0198
AC XY:
7207
AN XY:
363249
show subpopulations
African (AFR)
AF:
0.00155
AC:
41
AN:
26394
American (AMR)
AF:
0.0155
AC:
544
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00150
AC:
29
AN:
19384
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30202
South Asian (SAS)
AF:
0.0486
AC:
2629
AN:
54140
European-Finnish (FIN)
AF:
0.0423
AC:
1714
AN:
40524
Middle Eastern (MID)
AF:
0.0102
AC:
42
AN:
4134
European-Non Finnish (NFE)
AF:
0.0173
AC:
14604
AN:
841815
Other (OTH)
AF:
0.0178
AC:
819
AN:
46082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
843
1685
2528
3370
4213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0157
AC:
1752
AN:
111916
Hom.:
17
Cov.:
23
AF XY:
0.0166
AC XY:
565
AN XY:
34084
show subpopulations
African (AFR)
AF:
0.00259
AC:
80
AN:
30885
American (AMR)
AF:
0.0163
AC:
172
AN:
10532
Ashkenazi Jewish (ASJ)
AF:
0.00189
AC:
5
AN:
2647
East Asian (EAS)
AF:
0.000564
AC:
2
AN:
3549
South Asian (SAS)
AF:
0.0464
AC:
124
AN:
2672
European-Finnish (FIN)
AF:
0.0410
AC:
248
AN:
6053
Middle Eastern (MID)
AF:
0.00461
AC:
1
AN:
217
European-Non Finnish (NFE)
AF:
0.0206
AC:
1096
AN:
53157
Other (OTH)
AF:
0.0125
AC:
19
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
56
112
168
224
280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0154
Hom.:
117
Bravo
AF:
0.0134
EpiCase
AF:
0.0183
EpiControl
AF:
0.0182

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 30, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Nov 24, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.1
DANN
Benign
0.59
PhyloP100
-0.30
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41298498; hg19: chrX-73961794; API